Free Trial

This company recently went public with an IPO on Friday, May 8th 2026. They issued 15,500,000 shares at $16.00 - $18.00 per share. We will continue to update data for ODTX as it becomes available.

Odyssey Therapeutics (ODTX) Insider Trading & Ownership

$17.45 +1.03 (+6.27%)
As of 05/11/2026 04:00 PM Eastern

Odyssey Therapeutics (NASDAQ:ODTX) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
5
Amount Of
Insider Buying
(Last 12 Months)
$30.32M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$32.04K
Get ODTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Odyssey Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ODTX Insider Buying and Selling by Quarter

Odyssey Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/11/2026
Nan (Ln) Li
Director
Buy1,111,111$18.00$19,999,998.00  
5/11/2026
Shelley Chu
Director
Buy11,111$18.00$199,998.00  
5/8/2026
Jason Haas
CFO
Buy1,000$20.00$20,000.00  
5/8/2026
Jeffrey M Leiden
Director
Buy5,000$20.00$100,000.00  
(Data available from 1/1/2013 forward)

ODTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Odyssey Therapeutics includes Jason Haas, Jeffrey M Leiden, Nan (Ln) Li, Shelley Chu, and Sr One Capital Management, Llc. Learn more on insiders at ODTX.

The following insiders have purchased ODTX shares in the last 24 months: Jason Haas ($20,000.00), Jeffrey M Leiden ($100,000.00), Nan (Ln) Li ($19,999,998.00), Shelley Chu ($199,998.00), and Sr One Capital Management, Llc ($9,999,990.00).

Insiders have purchased a total of 1,683,777 ODTX shares in the last 24 months for a total of $30,319,986.00 bought.

The following insider sold ODTX shares in the last 24 months: Sr One Capital Management, Llc ($32,040.00).

Insiders have sold a total of 1,780 Odyssey Therapeutics shares in the last 24 months for a total of $32,040.00 sold.



This page (NASDAQ:ODTX) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners